REPARE THERAPEUTICS INC (RPTX)

US7602731025 - Common Stock

1.32  0 (0%)

After market: 1.33 +0.01 (+0.76%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
7.6M
7,500.00%
131.8M
1,634.21%
51.133M
-61.20%
57.894M
13.22%
6.85M
-88.17%
19.629M
186.55%
29.426M
49.91%
103.18M
250.64%
257.04M
149.12%
477.36M
85.71%
EBITDA
YoY % growth
-107.23M
-103.86%
-17.82M
83.38%
-114.273M
-541.26%
-107.161M
6.22%
-179.512M
-67.52%
-180.917M
-0.78%
N/AN/AN/AN/A
EBIT
YoY % growth
-108.7M
-103.18%
-19.8M
81.78%
-116.224M
-486.99%
-103.092M
11.30%
-161.812M
-56.96%
-170.298M
-5.24%
-166.898M
2.00%
-165.787M
0.67%
-246.84M
-48.89%
-90.576M
63.31%
Operating Margin
-1,430.26%-15.02%-227.30%-178.07%-2,362.22%-867.58%-567.18%-160.68%-96.03%-18.97%
EPS
YoY % growth
-2.82
-38.52%
-0.78
72.34%
-2.23
-185.90%
-2.19
1.96%
-2.97
-35.69%
-2.29
22.72%
-2.41
-5.22%
-0.29
88.16%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.85
-26.26%
-0.76
-353.30%
-0.74
9.39%
-0.76
6.56%
-0.82
3.33%
Revenue
Q2Q % growth
2.788M
-78.63%
1.99M
-96.20%
1.99M
85.46%
1.99M2.387M
-14.38%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-36.829M
-19.32%
-38.123M
-712.63%
-38.805M
4.36%
-39.412M
2.03%
-38.933M
-5.71%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.81
-80.00%
-0.890.088.83%
Q2 2024
Q2Q % growth
-0.82
-192.86%
-0.890.077.44%
Q1 2024
Q2Q % growth
0.30
136.14%
0.020.281,772.17%
Q4 2023
Q2Q % growth
-0.67
10.67%
-0.37-0.30-83.19%
Q3 2023
Q2Q % growth
-0.45
-126.32%
-0.880.4348.63%
Q2 2023
Q2Q % growth
-0.28
69.23%
-0.800.5264.81%
Q1 2023
Q2Q % growth
-0.83 -0.82-0.01-0.64%
Q4 2022
Q2Q % growth
-0.75
-7.14%
-0.74-0.01-1.88%
Q3 2022
Q2Q % growth
1.71
306.02%
-0.912.62288.79%
Q2 2022
Q2Q % growth
-0.91
-28.17%
-0.86-0.05-5.37%
Q1 2022
Q2Q % growth
-0.83
-43.10%
-0.870.044.91%
Q4 2021
Q2Q % growth
-0.70
-70.73%
-0.750.057.26%
Q3 2021
Q2Q % growth
-0.83
-124.32%
-0.72-0.11-14.61%
Q2 2021
Q2Q % growth
-0.71
71.02%
-0.62-0.09-15.05%
Q1 2021
Q2Q % growth
-0.58 -0.52-0.06-12.38%
Q4 2020
Q2Q % growth
-0.41 -0.40-0.01-1.76%
Q3 2020
Q2Q % growth
-0.37 -0.390.024.12%
Q2 2020
Q2Q % growth
-2.45 -0.06-2.39-4,077.32%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth

-100.00%
2.788M-2.788M-100.00%
Q2 2024
Q2Q % growth
1.073M
-96.45%
2.983M-1.91M-64.03%
Q1 2024
Q2Q % growth
52.404M
822.93%
39.168M13.236M33.79%
Q4 2023
Q2Q % growth
13.047M
-28.31%
19.309M-6.262M-32.43%
Q3 2023
Q2Q % growth
2.159M
-98.08%
6.436M-4.277M-66.45%
Q2 2023
Q2Q % growth
30.249M
4,221.29%
7.837M22.412M285.98%
Q1 2023
Q2Q % growth
5.678M
1,319.50%
6.242M-564K-9.04%
Q4 2022
Q2Q % growth
18.2M
163.77%
8.279M9.921M119.83%
Q3 2022
Q2Q % growth
112.5M
37,400.00%
1.612M110.888M6,878.91%
Q2 2022
Q2Q % growth
700K
133.33%
1.989M-1.289M-64.81%
Q1 2022
Q2Q % growth
400K
100.00%
2.399M-1.999M-83.33%
Q4 2021
Q2Q % growth
6.9M
6,800.00%
3.342M3.558M106.46%
Q3 2021
Q2Q % growth
300K 142.657K157.343K110.29%
Q2 2021
Q2Q % growth
300K 612K-312K-50.98%
Q1 2021
Q2Q % growth
200K 637.5K-437.5K-68.63%
Q4 2020
Q2Q % growth
100K 1.275M-1.175M-92.16%
Q3 2020
Q2Q % growth
1.02M-1.02M-100.00%
Q2 2020
Q2Q % growth
17M-17M-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 2.75% 5.03%
Revenue0% 0% -0.12% -4.15%